What follow-up schedule and preventive treatment should be started for a patient with cluster headache?

Cluster Headache Follow-up and Prevention

For cluster headache patients, initiate verapamil at 240 mg daily as first-line preventive therapy, titrating upward based on attack control, with follow-up every 1-2 weeks during active cluster periods until attacks are suppressed, then continue treatment for 2 weeks after the cluster period ends before tapering. 1, 2

Preventive Treatment Strategy

First-Line Prevention: Verapamil

• Start verapamil 240 mg daily (divided doses: 40 mg morning, 80 mg afternoon, 80 mg evening) 1, 2
• Titrate systematically: Increase by 40 mg every 2 days based on attack timing 3
  • If nocturnal attacks predominate: increase evening dose first
  • If attacks occur upon waking: set alarm 2 hours before usual wake time to take medication
• Target dose: Most patients require 200-480 mg daily; some need up to 960 mg 3
• Monitor ECG at doses above 360 mg due to PR interval prolongation risk 4
• Efficacy: Achieves complete relief in 94% of episodic cluster headache, 55% of chronic cluster headache 3

Transitional/Bridge Therapy

Use during verapamil titration to provide immediate relief:

• Corticosteroids (preferred): Prednisone 100 mg daily orally or methylprednisolone up to 500 mg IV daily for 5 days 2
  • Limit use to ≤2 weeks if possible 5
  • Taper once verapamil reaches therapeutic effect
• Greater occipital nerve block: Alternative bridge option 2

Second-Line Prevention Options

If verapamil fails or is not tolerated:

• Galcanezumab: Effective for episodic cluster headache (weak recommendation against for chronic cluster headache) 1
• Lithium, topiramate, valproic acid: Alternative preventives 2
• Melatonin, gabapentin: Additional options 5

Follow-up Schedule

Active Cluster Period

• Weekly visits until attacks are controlled 3
• Monitor attack frequency, timing, severity via headache diary
• Adjust verapamil dose based on response
• Check ECG if dose exceeds 360 mg

After Attack Control

• Continue same verapamil dose for 2 additional weeks after cluster period ends 3
• Then begin systematic dose reduction
• For chronic cluster headache: review as often as necessary 3

Long-term Monitoring

• Track for transformation from episodic to chronic (occurs in ~3% annually) 6
• Monitor for medication overuse if using acute treatments frequently
• Reassess preventive therapy need at each cluster period

Acute Attack Management During Follow-up

Ensure patients have effective acute treatments:

• Subcutaneous sumatriptan 6 mg OR intranasal zolmitriptan 10 mg 1, 2
• High-flow oxygen (100%) at ≥12 L/min for 15 minutes 1, 2

Critical Pitfalls to Avoid

• Underdosing verapamil: Most patients need >240 mg; don't stop titration prematurely 3
• Inadequate follow-up frequency: Weekly monitoring during active periods is essential for dose optimization 3
• Premature discontinuation: Continue verapamil for 2 weeks after cluster ends before tapering 3
• Missing chronic transformation: Only 55% of chronic cluster headache patients achieve complete relief with verapamil alone; earlier specialist referral may be needed 3
• Gender differences: Women with chronic cluster headache respond less favorably (20% vs 69% in men); consider earlier escalation to second-line therapies 3

Treatment Failure Management

If verapamil at adequate doses (480-720 mg) fails:

• Add lithium, topiramate, or valproic acid as combination therapy 4
• Consider galcanezumab for episodic cluster headache 1
• For drug-resistant chronic cluster headache: refer for neuromodulation (occipital nerve stimulation or deep brain stimulation) 4